Skip to content

Galantamine

Published: July 26, 2026Updated: July 26, 2026

Galantamine is a cholinesterase inhibitor used to treat cognitive symptoms in patients with mild to moderate Alzheimer's disease. It works by increasing acetylcholine levels in the brain, a neurotransmitter that becomes depleted as the disease progresses. This medication helps improve memory, thinking, and daily functioning in affected patients.

Quick summary

Galantamine treats mild to moderate Alzheimer's disease by inhibiting an enzyme that breaks down acetylcholine, thereby increasing this key neurotransmitter in the brain.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

ATC
N06DA04
RxNorm
4637
Generic
Galantamine
Class
atc-n06
Brands
—
Availability
rx
Lactation
unknown
Routes
oral
Forms
capsule, tablet, solution
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Doses exceeding 100mg in a single administration may cause serious toxicity
Chronic overdose: Prolonged use exceeding recommended daily doses may lead to cumulative cholinergic effects
Immediate actions
Activate emergency medical services, administer activated charcoal if presentation is within 1 hour, provide supportive care
Antidote
No specific antidote exists(Supportive care is the primary treatment approach)
Poison Control: 1-800-222-1222

Special Populations

12 groups
✗

pregnancy

first trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

second trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

use with extreme caution

Key Recommendations

use only if benefits outweigh risks; may affect fetus near delivery

Monitor

fetal monitoring and assessment of newborn after delivery

Use with caution and monitor for adverse effects.

?

lactation

breastfeeding
unknown
FDA Category
N
Dose Adjustment

avoid

Key Recommendations

not recommended during breastfeeding; discontinue breastfeeding or discontinue drug

Monitor

monitor infant for adverse effects

⚠

geriatric

elderly
caution
FDA Category
N
Dose Adjustment

start at low end of dosing range

Key Recommendations

use with caution; may be more sensitive to cholinergic effects

Monitor

monitor for gastrointestinal adverse effects and bradycardia

Use with caution and monitor for adverse effects.

✗

pediatric_age

children adolescents
unsafe
FDA Category
N
Dose Adjustment

not recommended

Key Recommendations

not indicated for use in pediatric patients; safety and efficacy not established

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

renal_impairment

mild
caution
FDA Category
N
Dose Adjustment

no adjustment needed

Key Recommendations

no dosage adjustment required for mild renal impairment

Monitor

monitor renal function periodically

Use with caution and monitor for adverse effects.

⚠

renal_impairment

moderate
caution
FDA Category
N
Dose Adjustment

reduce dose

Key Recommendations

reduce dose; consider starting at 4mg once daily

Monitor

monitor renal function and for adverse effects

Use with caution and monitor for adverse effects.

✗

renal_impairment

severe
unsafe
FDA Category
N
Dose Adjustment

avoid

Key Recommendations

use not recommended in severe renal impairment; contraindicated

Monitor

monitor renal function

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

hepatic_impairment

mild
caution
FDA Category
N
Dose Adjustment

no adjustment needed

Key Recommendations

no dosage adjustment required for mild hepatic impairment

Monitor

monitor hepatic function periodically

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

moderate
caution
FDA Category
N
Dose Adjustment

reduce dose

Key Recommendations

reduce dose; consider starting at 4mg once daily

Monitor

monitor hepatic function and for adverse effects

Use with caution and monitor for adverse effects.

✗

hepatic_impairment

severe
unsafe
FDA Category
N
Dose Adjustment

avoid

Key Recommendations

use not recommended in severe hepatic impairment; contraindicated

Monitor

monitor hepatic function

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

prescribingFDA
2023

FDA approval year

Value:2001

FDA approval for Alzheimer's disease treatment

drug_classWHO
2023

Drug class

Value:Cholinesterase inhibitor

Pharmacological classification

usageMedical guidelines
2023

Common uses

Value:Alzheimer's disease treatment

Primary therapeutic indication

mechanismFDA
2023

Mechanism of action

Value:Acetylcholinesterase inhibition

Pharmacodynamic properties

Treatment of mild to moderate dementia of the Alzheimer's type to improve cognitive function, memory, and activities of daily living.

Galantamine reversibly inhibits acetylcholinesterase, an enzyme that breaks down acetylcholine. By preventing this breakdown, it increases acetylcholine availability at neuronal synapses in the brain, compensating for the cholinergic neuron loss seen in Alzheimer's disease.

Common side effects include nausea, vomiting, diarrhea, decreased appetite, and dizziness—usually occurring early in treatment. Should be taken with food to minimize gastrointestinal effects. Use cautiously in patients with cardiac conditions, seizures, or asthma. Dose titration is required; starting dose is typically 4mg twice daily with gradual increases. Not a cure for Alzheimer's disease but may slow symptom progression.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy